Literature DB >> 25411564

Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient.

Ashley Munchel1, Allen Chen2, Heather Symons2.   

Abstract

Hematopoietic cell transplantation is the only potentially curative option for a variety of pediatric malignant and nonmalignant disorders. Despite advances in transplantation biology and immunology as well as in posttransplant management that have contributed to improved survival and decreased transplant-related mortality, hematopoietic cell transplantation does not come without significant risk of complications. When patients who have undergone hematopoietic cell transplantation present to the emergency department, it is important to consider a variety of therapy-related complications to optimize management and outcome. In this article, we use clinical cases to highlight some of the more common emergent complications after hematopoietic cell transplantation.

Entities:  

Keywords:  bronchiolitis obliterans; calcineurin inhibitor; congestive heart failure; diffuse alveolar hemorrhage; graft-versus-host disease; hematopoietic cell transplantation; hemorrhagic cystitis; idiopathic pulmonary syndrome; immunosuppression; infection; posterior reversible encephalopathy; thrombotic microangiopathy

Year:  2011        PMID: 25411564      PMCID: PMC4234095          DOI: 10.1016/j.cpem.2011.07.005

Source DB:  PubMed          Journal:  Clin Pediatr Emerg Med        ISSN: 1522-8401


  103 in total

1.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.

Authors:  J Douglas Rizzo; John R Wingard; Andre Tichelli; Stephanie J Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

Review 2.  Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.

Authors:  S Z Pavletic; S J Lee; G Socie; G Vogelsang
Journal:  Bone Marrow Transplant       Date:  2006-09-18       Impact factor: 5.483

3.  Use of high-dose corticosteroids and high-frequency oscillatory ventilation for treatment of a child with diffuse alveolar hemorrhage after bone marrow transplantation: case report and review of the literature.

Authors:  D J Haselton; J G Klekamp; B W Christman; F E Barr
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

4.  Characterization of a reproducible rat model of hepatic veno-occlusive disease.

Authors:  L D DeLeve; R S McCuskey; X Wang; L Hu; M K McCuskey; R B Epstein; G C Kanel
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

Authors:  W Scheef; H O Klein; N Brock; H Burkert; U Günther; H Hoefer-Janker; D Mitrenga; J Schnitker; R Voigtmann
Journal:  Cancer Treat Rep       Date:  1979-03

6.  Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.

Authors:  Rudolf Pihusch; Christoph Salat; Edwin Schmidt; Peter Göhring; Markus Pihusch; Erhard Hiller; Ernst Holler; Hans-Jochem Kolb
Journal:  Transplantation       Date:  2002-11-15       Impact factor: 4.939

7.  Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.

Authors:  Deborah Siegal; Anne Keller; Wei Xu; Sandeep Bhuta; Dong Hwan Kim; John Kuruvilla; Jeffrey H Lipton; Hans Messner; Vikas Gupta
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-21       Impact factor: 5.742

8.  Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.

Authors:  L A Levine; D F Jarrard
Journal:  J Urol       Date:  1993-04       Impact factor: 7.450

9.  Evaluation of intravesical alum irrigation for massive bladder hemorrhage.

Authors:  M Takashi; A Kondo; K Kato; T Murase; K Miyake
Journal:  Urol Int       Date:  1988       Impact factor: 2.089

10.  Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children.

Authors:  Ron Ben-Abraham; Gideon Paret; Rinat Cohen; Oded Szold; Gabriel Cividalli; Amos Toren; Arnon Nagler
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  4 in total

1.  Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life.

Authors:  J M Snaman; A C Talleur; J Lu; D R Levine; E C Kaye; A Sykes; Z Lu; B M Triplett; J N Baker
Journal:  Bone Marrow Transplant       Date:  2017-11-13       Impact factor: 5.483

2.  Health-Related Quality of Life among Children and Adolescents during Hematopoietic Stem Cell Transplant Recovery.

Authors:  Cheryl Rodgers; Patricia Wills-Bagnato; Richard Sloane; Marilyn Hockenberry
Journal:  J Pediatr Oncol Nurs       Date:  2015-01-15       Impact factor: 1.636

3.  Family Adjustment to Pediatric Hematopoietic Stem Cell Transplant During COVID-19.

Authors:  Marie L Chardon; Kimberly L Klages; Naomi E Joffe; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2021-10-18

4.  Racial and Ethnic Differences in Inpatient Palliative Care for Pediatric Stem Cell Transplant Patients.

Authors:  Maya N McKee; Brett K Palama; Matt Hall; James L LaBelle; Nicole L Bohr; K Sarah Hoehn
Journal:  Pediatr Crit Care Med       Date:  2022-02-22       Impact factor: 3.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.